Market Place
Sourcing Support
Allay Therapeutics Expands Advisory Boards For Pain Management
24 Oct 2024 //
BUSINESSWIRE
Allay FDA Accepts IND For ATX101 Pivotal Trial In Knee Surgery Pain
12 Jun 2024 //
BUSINESSWIRE
Brandon Capital raises $180M for Australia, New Zealand biotechs
04 Jun 2024 //
FIERCE BIOTECH
Allay`s ATX101 Enables 4 Weeks Post-Surgical Pain Relief
11 Apr 2024 //
BUSINESSWIRE
Allay Announces Development Agreement with Maruishi
18 Dec 2023 //
BUSINESSWIRE
Allay Therapeutics Appoints Nicole Vitullo to Board of Directors
06 Sep 2023 //
BUSINESSWIRE
Evonik backs Allay`s development of pain therapy implants
14 Dec 2022 //
FIERCEPHARMA
Allay Therapeutics Appoints Ron Burch, M.D., Ph.D. to Scientific Advisory Board
27 Jan 2022 //
BUSINESSWIRE
Allay Therapeutics rakes in $60M for `tunable` pain treatment
15 Sep 2021 //
PRESS RELEASE
Allay Therapeutics Completes $60M Financing for Ultra-Sustained Pain Platform
15 Sep 2021 //
BUSINESSWIRE
Allay Therapeutics Appoints David Hewitt, M.D. as Chief Medical Officer
07 Jul 2021 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.